drug ineffective; covid-19; this is a spontaneous report received from a contactable reporter(s) (consumer or other non hcp) from the ra and product quality group. the reporter is the patient. a 34 year-old female patient received bnt162b2 (bnt162b2), administration date 02jun2021 (lot number: ew3143) as dose 1, single and administration date 21jul2021 (lot number: fe1510) as dose 2, single for covid-19 immunisation. the patient's relevant medical history and concomitant medications were not reported. the following information was reported: drug ineffective (medically significant) with onset 05jan2022, outcome "recovered" (17jan2022), described as "drug ineffective"; suspected covid-19 (medically significant) with onset 05jan2022, outcome "recovered" (17jan2022), described as "covid-19". additional information: patient last menstrual period date was reported as 21jan2022. no follow-up attempts are possible. no further information is expected.; sender's comments: linked report(s) : gb-pfizer inc-202200333912 same patient/drug and different dose/events (dose 2);gb-pfizer inc-202200323270 same patient/drug and different dose/events (dose 1)